Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01033227 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease
A Phase 1 study, sponsored by Children's Hospital Los Angeles.
- Terminated
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT01033227 is a Phase 1 study that was terminated before completion, run by Children's Hospital Los Angeles. The registered enrollment target is 5 participants.
The verdict
NCT01033227, a Phase 1 study, was terminated before completion, sponsored by Children's Hospital Los Angeles.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will determine if administration of sodium nitrite is safe and can improve small vessel blood flow and tissue oxygenation when given as an additional treatment in patients with acute vaso-occlusive crisis (pain crisis) associated with sickle cell disease.
Interventions
- DRUG sodium nitrite injection, usp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01033227
The ClinicalTrials.gov registry entry for NCT01033227 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sodium nitrite injection, usp is the first listed.
NCT01033227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01033227 about?
NCT01033227 is a clinical study titled "Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease". This study will determine if administration of sodium nitrite is safe and can improve small vessel blood flow and tissue oxygenation when given as an additional treatment in patients with acute vaso-occlusive crisis (pain crisis) associated with sickle cell disease.
What is the current status of trial NCT01033227?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2009-12. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01033227?
The interventions under investigation include: sodium nitrite injection, usp (DRUG).
Who is sponsoring clinical trial NCT01033227?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.